TELA Bio Statistics

Total Valuation

TELA Bio has a market cap or net worth of $54.98 million. The enterprise value is $54.74 million.

Market Cap	54.98M
Enterprise Value	54.74M

Important Dates

The last earnings date was Thursday, May 8, 2025, after market close.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

TELA Bio has 39.55 million shares outstanding. The number of shares has increased by 39.15% in one year.

Current Share Class	39.55M
Shares Outstanding	39.55M
Shares Change (YoY)	+39.15%
Shares Change (QoQ)	+12.96%
Owned by Insiders (%)	7.93%
Owned by Institutions (%)	36.13%
Float	22.37M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.66
Forward PS	0.56
PB Ratio	3.03
P/TBV Ratio	3.34
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.77
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.22, with a Debt / Equity ratio of 2.35.

Current Ratio	4.22
Quick Ratio	3.23
Debt / Equity	2.35
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-7.68

Financial Efficiency

Return on equity (ROE) is -267.29% and return on invested capital (ROIC) is -42.14%.

Return on Equity (ROE)	-267.29%
Return on Assets (ROA)	-33.34%
Return on Invested Capital (ROIC)	-42.14%
Return on Capital Employed (ROCE)	-65.49%
Revenue Per Employee	$340,751
Profits Per Employee	-$207,866
Employee Count	209
Asset Turnover	0.96
Inventory Turnover	1.71

Taxes

Income Tax	-92,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -76.16% in the last 52 weeks. The beta is 0.67, so TELA Bio's price volatility has been lower than the market average.

Beta (5Y)	0.67
52-Week Price Change	-76.16%
50-Day Moving Average	1.14
200-Day Moving Average	2.34
Relative Strength Index (RSI)	61.85
Average Volume (20 Days)	152,842

Short Selling Information

The latest short interest is 580,689, so 1.47% of the outstanding shares have been sold short.

Short Interest	580,689
Short Previous Month	671,935
Short % of Shares Out	1.47%
Short % of Float	2.60%
Short Ratio (days to cover)	6.14

Income Statement

In the last 12 months, TELA Bio had revenue of $71.22 million and -$43.44 million in losses. Loss per share was -$1.29.

Revenue	71.22M
Gross Profit	48.04M
Operating Income	-39.76M
Pretax Income	-40.30M
Net Income	-43.44M
EBITDA	-38.73M
EBIT	-39.76M
Loss Per Share	-$1.29

Full Income Statement

Balance Sheet

The company has $42.83 million in cash and $42.59 million in debt, giving a net cash position of $241,000 or $0.01 per share.

Cash & Cash Equivalents	42.83M
Total Debt	42.59M
Net Cash	241,000
Net Cash Per Share	$0.01
Equity (Book Value)	18.12M
Book Value Per Share	0.46
Working Capital	53.21M

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 67.46%, with operating and profit margins of -55.83% and -61.00%.

Gross Margin	67.46%
Operating Margin	-55.83%
Pretax Margin	-61.13%
Profit Margin	-61.00%
EBITDA Margin	-54.38%
EBIT Margin	-55.83%
FCF Margin	n/a

Dividends & Yields

TELA Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-39.15%
Shareholder Yield	-39.15%
Earnings Yield	-79.02%
FCF Yield	n/a

Analyst Forecast

The average price target for TELA Bio is $6.00, which is 331.66% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.00
Price Target Difference	331.66%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	25.47%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TELA Bio has an Altman Z-Score of -5.62 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.62
Piotroski F-Score	1